Identification of Integrin αvβ3 as a Receptor for the Novel Macrophage-Secreted Microprotein U9-ORF Encoded by U90926 2307000

Abstract Introduction Gene expression in macrophages is a highly dynamic and tightly regulated process to prevent inflammation-driven pathology, such as septic shock. Previous studies in our lab identified the putative long non-coding RNA (lncRNA) gene U90926 as highly induced in macrophages following pattern recognition receptor activation by lipopolysaccharide (LPS) and other microbial ligands. Using an LPS-induced sepsis model, we found that U90926 knockout mice exhibited greater disease severity and mortality, indicating a protective role of the gene. Surprisingly, analysis of U90929 sequence identified an 87 amino acid open reading frame (ORF), encoding a novel protein, U9-ORF, containing a functional N-terminal secretion signal. We therefore hypothesized that protective effects of U90926 in sepsis are mediated by the secretion of U9-ORF and binding to receptors on other cells. Methods To screen for potential receptors for U9-ORF, we developed recombinant U9-ORF-Fc fusion proteins to measure binding via flow cytometry, and for use in vitro functional assays. Transfection of HEK293 cells was used to express potential receptors for U9-ORF, and cellular adhesion assays were used as a functional readout. Results Multiple sequence alignments of predicted U9-ORF homologs revealed a conserved C-terminal RGD motif, suggesting that U9-ORF could bind specific integrins. Flow cytometry assays demonstrated that U9-ORF preferentially bound cells expressing integrin αvβ3, but not αIIbβ3, in an RGD- and divalent cation-dependent manner. Plate-bound U9-ORF-Fc supported cellular adhesion and spreading of cells expressing αvβ3 integrin, in an RGD-dependent manner. Conclusion U9-ORF is a novel ligand for integrin αvβ3, which is upregulated on endothelial cells during inflammation, and thus could mediate protective effects of U90926 in sepsis. Ongoing experiments aim to determine the effects of U9-ORF on endothelial barrier integrity in the presence of inflammatory stimuli. Funding Source NIAID/NIH R03 AI190196-01; NIAID/NIH R21 AI151116-01; Department of Education CMB-GAANN Fellowship Topic Categories Cellular Adhesion, Migration, and Inflammation (CAM)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2026-07-28
DOI
https://doi.org/10.1093/jimmun/vkag141.1359
Primary Topic
Cell Adhesion Molecules Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identification of Integrin αvβ3 as a Receptor for the Novel Macrophage-Secreted Microprotein U9-ORF Encoded by U90926 2307000

Tyler Hogan, Dimitry Krementsov
The Journal of Immunology
Cell Adhesion Molecules Research
article

Identification of Integrin αvβ3 as a Receptor for the Novel Macrophage-Secreted Microprotein U9-ORF Encoded by U90926 2307000

Tyler Hogan, Dimitry Krementsov
article en

Abstract

Abstract Introduction Gene expression in macrophages is a highly dynamic and tightly regulated process to prevent inflammation-driven pathology, such as septic shock. Previous studies in our lab identified the putative long non-coding RNA (lncRNA) gene U90926 as highly induced in macrophages following pattern recognition receptor activation by lipopolysaccharide (LPS) and other microbial ligands. Using an LPS-induced sepsis model, we found that U90926 knockout mice exhibited greater disease severity and mortality, indicating a protective role of the gene. Surprisingly, analysis of U90929 sequence identified an 87 amino acid open reading frame (ORF), encoding a novel protein, U9-ORF, containing a functional N-terminal secretion signal. We therefore hypothesized that protective effects of U90926 in sepsis are mediated by the secretion of U9-ORF and binding to receptors on other cells. Methods To screen for potential receptors for U9-ORF, we developed recombinant U9-ORF-Fc fusion proteins to measure binding via flow cytometry, and for use in vitro functional assays. Transfection of HEK293 cells was used to express potential receptors for U9-ORF, and cellular adhesion assays were used as a functional readout. Results Multiple sequence alignments of predicted U9-ORF homologs revealed a conserved C-terminal RGD motif, suggesting that U9-ORF could bind specific integrins. Flow cytometry assays demonstrated that U9-ORF preferentially bound cells expressing integrin αvβ3, but not αIIbβ3, in an RGD- and divalent cation-dependent manner. Plate-bound U9-ORF-Fc supported cellular adhesion and spreading of cells expressing αvβ3 integrin, in an RGD-dependent manner. Conclusion U9-ORF is a novel ligand for integrin αvβ3, which is upregulated on endothelial cells during inflammation, and thus could mediate protective effects of U90926 in sepsis. Ongoing experiments aim to determine the effects of U9-ORF on endothelial barrier integrity in the presence of inflammatory stimuli. Funding Source NIAID/NIH R03 AI190196-01; NIAID/NIH R21 AI151116-01; Department of Education CMB-GAANN Fellowship Topic Categories Cellular Adhesion, Migration, and Inflammation (CAM)

The Journal of ImmunologyVol. 215(Supplement_1)
University of Vermont (US)
Good health and well-being
Openalex Percentile: Top 10%
Cell Adhesion Molecules Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.